Interleukin-20 is involved in dry eye disease and is a potential therapeutic target

Hsiao-Hsuan Wang,Wei-Yu Chen,Yi-Hsun Huang,Sheng-Min Hsu,Yeou-Ping Tsao,Yu-Hsiang Hsu,Ming-Shi Chang
DOI: https://doi.org/10.1186/s12929-022-00821-2
2022-06-10
Journal of Biomedical Science
Abstract:Dry eye disease (DED) is a common disease in ophthalmology, affecting millions of people worldwide. Recent studies have shown that inflammation is the core mechanism of DED. IL-20 is a proinflammatory cytokine involved in various inflammatory diseases. Therefore, we aimed to explore the role of this cytokine in the pathogenesis of DED and evaluate the therapeutic potential of the anti-IL-20 monoclonal antibody (mAb) 7E for DED treatment.
cell biology,medicine, research & experimental
What problem does this paper attempt to address?